Silo Pharma, Inc. (SILO)
1.458
-0.04
(-2.80%)
USD |
NASDAQ |
Oct 02, 16:00
1.21
-0.25
(-17.01%)
After-Hours: 20:00
Silo Pharma EPS Diluted (Quarterly) : -0.7581 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7581 |
| March 31, 2026 | -1.802 |
| December 31, 2025 | -0.9928 |
| September 30, 2025 | -1.785 |
| June 30, 2025 | -2.877 |
| March 31, 2025 | -0.23 |
| December 31, 2024 | -5.789 |
| September 30, 2024 | -0.2159 |
| June 30, 2024 | -0.3052 |
| March 31, 2024 | -0.2796 |
| December 31, 2023 | -0.3858 |
| September 30, 2023 | -0.2124 |
| June 30, 2023 | -0.3212 |
| March 31, 2023 | -0.2869 |
| December 31, 2022 | -0.5264 |
| September 30, 2022 | -0.4914 |
| June 30, 2022 | -0.331 |
| March 31, 2022 | -0.306 |
| December 31, 2021 | -0.552 |
| September 30, 2021 | 3.202 |
| June 30, 2021 | -0.2385 |
| March 31, 2021 | -20.56 |
| December 31, 2020 | -6.96 |
| September 30, 2020 | -5.632 |
| June 30, 2020 | -2.056 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.506 |
| December 31, 2019 | -0.8125 |
| September 30, 2019 | -0.5655 |
| June 30, 2019 | -0.5165 |
| March 31, 2019 | -0.2635 |
| September 30, 2018 | -0.19 |
| June 30, 2018 | -0.3155 |
| March 31, 2018 | 0.0175 |
| December 31, 2017 | 0.2065 |
| September 30, 2017 | -0.5185 |
| June 30, 2017 | -0.076 |
| March 31, 2017 | 0.50 |
| December 31, 2016 | -0.143 |
| September 30, 2016 | -0.431 |
| June 30, 2016 | -0.4335 |
| March 31, 2016 | -0.103 |
| December 31, 2015 | 0.0065 |
| September 30, 2015 | -0.4555 |
| June 30, 2015 | 0.016 |
| March 31, 2015 | 0.028 |
| December 31, 2014 | -0.046 |
| September 30, 2014 | -0.3315 |
| June 30, 2014 | -0.4445 |
| March 31, 2014 | 0.5175 |
| December 31, 2013 | 0.1035 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8328M |
| Total Expenses (Quarterly) | 0.8328M |
| Enterprise Value | -3.787M |
| Earnings Yield | -366.1% |
| Normalized Earnings Yield | -358.48 |